insights_auto
Why is REGN34 up 4,18%?
Dive Deeperchevron_right
REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
67,76 BRL
arrow_upward
+4,18%(+2,72) 1D
15-окт., 12:56:13 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
65,71 BRL
High
67,76 BRL
Low
65,71 BRL
Mkt. cap
81,99 млд
Avg. vol.
712,00
Volume
1,50 миң
52-wk high
73,13 BRL
52-wk low
49,91 BRL
Shares outstanding
101,14 млн
No. of employees
15 миң
Open
65,71 BRL
High
67,76 BRL
Low
65,71 BRL
Mkt. cap
81,99 млд
Avg. vol.
712,00
Volume
1,50 миң
52-wk high
73,13 BRL
52-wk low
49,91 BRL
Shares outstanding
101,14 млн
No. of employees
15 миң
News stories
From web sources and news partners
Yahoo Finance
·
7 саат мурун
What to Expect From Regeneron Pharmaceuticals' Next Quarterly Earnings Report
MarketBeat
·
8 саат мурун
2,188 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by B.A. Schrock Wealth Management Inc.
Simply Wall Street
·
10 саат мурун
Regeneron (REGN) Stock Looks Below Fair Value On Earnings
Seeking Alpha
·
22 саат мурун
Regeneron a new Buy at UBS as Street undervalues Dupixent's future
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15,3 миң
Founded1988
HeadquartersТарритаун, Нью Йорк, Америка Кошмо Штаттары
Sector-
Websiteregeneron.com